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Delayed blastulation,
multinucleation, and expansion
grade are independently associated
with live-birth rates in frozen
blastocyst transfer cycles
Nina Desai, Ph.D., Stephanie Ploskonka, M.S., Linnea Goodman, M.D., Marjan Attaran, M.D.,
Jeffrey M. Goldberg, M.D., Cynthia Austin, M.D., and Tommaso Falcone, M.D.
Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland Clinic Fertility Center, Beachwood, OhioObjective: To identify blastocyst features independently predictive of successful pregnancy and live births with vitriﬁed-warmed
blastocysts.
Design: Retrospective study.
Setting: Academic hospital.
Patient(s): Women undergoing a cycle with transfer of blastocysts vitriﬁed using the Rapid-i closed carrier (n ¼ 358).
Intervention(s): None.
Main Outcome Measure(s): Clinical pregnancy and live-birth rates analyzed using logistic regression analysis.
Result(s): A total of 669 vitriﬁed-warmed blastocysts were assessed. The survival ratewas 95%.Amean of 1.7 0.5 embryoswere transferred.
The clinical pregnancy, live-birth, and implantation rates were 55%, 46%, and 43%, respectively. The odds of clinical pregnancy (odds ratio [OR]
3.08; 95% conﬁdence interval [CI], 1.88–5.12) and live birth (OR 2.93; 95% CI, 1.79–4.85) were three times higher with day-5 blastocysts versus
slower-growing day-6 vitriﬁed blastocysts, irrespective of patient age at cryopreservation. Blastocysts frommultinucleated embryoswere half as
likely to result in a live birth (OR 0.46; 95%CI, 0.22–0.91). A four -fold increase in live birthwas observed if an expanded blastocystwas available
for transfer. The inner cell mass–trophectoderm score correlated to positive outcomes in the univariate analysis. The implantation rate was
statistically signiﬁcantly higher for day-5 versus day-6 vitriﬁed blastocysts (50% vs. 29%, respectively).
Conclusion(s): The blastocyst expansion grade after warmingwas predictive of successful outcomes independent of the inner cell mass or
trophectoderm score. Delayed blastulation and multinucleation were independently associated with lower live-birth rates in frozen cycles.
Implantation potential of the frozen blastocysts available should be included in the decision-making process regarding embryo number for
transfer. (Fertil Steril2016;106:1370–8.2016TheAuthors. Published byElsevier Inc. onbehalf of theAmericanSociety for Reproductive
Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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fertility-and-sterility/posts/11523-delayed-blastulation-multinucleation-and-expansion-grade-are-independently-associated-with-
live-birth-rates-in-frozen-blastocyst-transfer-cyclesI n vitro fertilization (IVF) laboratorieshave recently been transitioning toperforming more day-5 and elective
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ture embryos to the blastocyst stage.
Furthermore, numerous reports citing
better endometrial receptivity in frozen
versus fresh cycles have led to a major
paradigm shift in IVF cycle manage-
ment, with more programs opting for
blastocyst freeze-all cycles. This shift
demands that laboratories also develop
robust blastocyst cryopreservation
programs.VOL. 106 NO. 6 / NOVEMBER 2016
Fertility and Sterility®Myriad factors can contribute to the success of frozen blas-
tocyst transfer cycles. The embryo culture system, blastocyst
developmental rate, quality of blastocysts, and cryopreserva-
tion methodology as well as endometrial priming need careful
analysis to optimize the frozen embryo transfer (FET) program.
The rate of embryonic development has been a reliable
indicator of embryo quality throughout the history of IVF.
Application of time-lapse technology has only served to
further emphasize the connection between the kinetics of
blastocyst development and implantation potential (1–8).
Fresh blastocyst transfer studies suggest that blastocysts
developing by day 5 of culture give rise to higher pregnancy
rates than embryos reaching the blastocyst stage by day 6
(9, 10). It is not clear whether this is due to impaired embryo
quality of day-6 blastocysts or asynchronous uterine environ-
ment with poor endometrial receptivity (11, 12). Analysis of
frozen outcomes with blastocysts vitriﬁed on day 5 or 6 and
replaced in a more synchronized endometrium may provide
a better understanding of the impact of delayed blastulation
on subsequent embryo competence.
Another question of interest is the reproductive competence
of blastocysts derived from embryos displaying multinucleated
blastomeres at the early cleavage stage. Often such embryos are
deselected from fresh transfers, but they may be cryopreserved
for a subsequent frozen transfer (4, 13–16). Trophectoderm
biopsies with genetic analysis indicate that not all blastocysts
derived from multinucleated embryos have an abnormal
chromosome complement (14, 17). Our study identiﬁed the
blastocyst features independently predictive of successful
pregnancy and live birth with vitriﬁed-warmed blastocysts.
MATERIALS AND METHODS
Vitriﬁcationusing theRapid- i carrier (Vitrolife)was introduced
into our clinical practice in January 2011 for embryo cryopres-
ervation. This study examines outcomes from 354 consecutive
cycles from 342 women returning to the Cleveland Clinic
Fertility Center for a frozen embryo transfer (FET) of blastocysts
betweenAugust 2011 andDecember2014.Noother selectionor
exclusion criteria were applied. Outcome data from our IVF
Laboratory Registry were retrospectively analyzed. This retro-
spective review of data collected during clinical IVF treatment
was performed with institutional review board approval.Ovarian Stimulation and IVF Protocol
Ovarian stimulation protocol selection was based on patient
age, serum antim€ullerian hormone levels, antral follicle counts,
and prior response to gonadotropins.Womenwere treated with
either a gonadotropin-releasing hormone (GnRH) agonist or a
GnRH antagonist to suppress ovulation until follicle maturity
was attained. In antagonist cycles, the GnRH antagonist was
administered when the lead follicle had reached 12 mm in
size. Recombinant follicle-stimulating hormone, with or
without urinary menotropins, was used for ovarian stimula-
tion. The ﬁnal follicular maturation was triggered with human
chorionic gonadotropin (hCG) or a GnRH agonist when at least
two lead follicles measured 18 mm in mean diameter. Oocytes
were collected 36 hours later by transvaginal ultrasound-
guided needle aspiration of follicles.VOL. 106 NO. 6 / NOVEMBER 2016Metaphase II oocytes were fertilized by intracytoplasmic
sperm injection (ICSI) 2 to 4 hours after the retrieval whereas
all other oocytes underwent conventional insemination.
Oocytes were examined 16 to 18 hours later for the presence
of two pronuclei. Zygotes were individually cultured in 25-mL
drops of Global medium (LifeGlobal) supplemented with 10%
Synthetic Protein Supplement (SPS; Cooper Surgical) under
an oil overlay. Culture was performed at 37C with 6% CO2
and 6% O2 in the EmbryoScope (n ¼ 179 cycles; Vitrolife)
or in conventional incubators (n ¼ 175 cycles). The embryos
that were not transferred were cultured up to day 6 for blas-
tocyst formation.Embryo Assessment
All embryos were observed and graded 42, 66, 90, 114, and
138 hours after insemination using conventional microscopy
or by viewing time-lapse video footage for embryos cultured
in the EmbryoScope (4). Cleavage-stage embryos were as-
sessed for blastomere number, symmetry, percentage of frag-
mentation, and degree of cell–cell adherence. Embryos were
screened for presence of multinucleation at the 2- to 5-cell
stage. Blastocysts were evaluated for expansion, inner cell
mass (ICM) development, and trophectoderm (TE) appearance
using the European Society of Human Reproduction and
Embryology (ESHRE) grading system (18). Blastocoel volume
and expansion were used to grade blastocysts as follows:
grade 1 ¼ early blastocyst, cavity just starting to form; grade
2 ¼ blastocyst, distinct blastocoel, zona not as yet thinned;
grade 3 ¼ expanded blastocyst with thin zona; and grade 4
¼ expanded blastocyst, hatching out of zona. The inner cell
mass was scored as 1 ¼ good, well deﬁned, with many com-
pacting, tightly adherent cells; 2 ¼ fair, discernible, but with
many cells loosely grouped; 3¼ poor, difﬁcult to discern with
very few cells. Blastocyst TE morphology based on overall cell
number and organization was also scored: 1 ¼ well orga-
nized, many cells forming cohesive epithelium; 2 ¼ fair,
few cells forming loose epithelium; 3¼ poor, low cell number,
and stretched appearance. Examples to illustrate blastocyst
grading are shown in Figure 1. Supplemental Videos 1 and 2
(available online) depict the two multinucleated embryos
from Figure 1 and their development to the blastocyst stage
(Fig. 1J and L).
The day of cryopreservation depended entirely on blasto-
cyst development. Blastocysts (grades 2 to 4) with good/fair
ICM–TE morphology (score 1–2) were selectively cryopre-
served on day 5. Blastocysts not reaching this benchmark
were given one more day in culture and frozen on day 6 if
they met these criteria.Vitriﬁcation Procedure
Blastocysts were cryopreserved using a two-step vitriﬁcation
protocol, as previously described in detail elsewhere (19).
Blastocoelic volume was reduced for all expanded or hatched
blastocysts before cryopreservation to maximize postwarm-
ing survival (19, 20). Blastocysts were equilibrated for 3 to
5 minutes in a 25-mL drop of solution containing 7.5%
dimethyl sulfoxide and 7.5% ethylene glycol with 20% SPS.1371
FIGURE 1
(A–D) Grading of blastocyst expansion. (A) Grade 1 early blastocyst. (B) Grade 2 blastocyst, distinct blastocoel. (C) Grade 3 expanded blastocyst.
(D) Grade 4 hatched blastocyst. The inner cell mass (ICM) and trophectoderm (TE) were scored separately. ICM morphology score: 1 ¼ good, well
deﬁned, many cells all tightly adhered; 2 ¼ fair, discernible with many cells loosely grouped; and 3 ¼ poor, difﬁcult to discern with few cells. TE
score: 1 ¼ good, many cells forming cohesive epithelium; 2 ¼ fair, few cells forming loose epithelium; and 3 ¼ poor, few cells, stretched
appearance. (E–H) Examples of ICM and TE scoring. (E) High-quality blastocyst with expansion grade 3, ICM 1, and TE 1. (F) Expanded
blastocyst, ICM 2, and TE 2: poor organization and low cell number, and TE with stretched appearance on one side. (G) Expanded TE 1
blastocyst with ICM 3. (H) Poor-quality blastocyst, ICM 3, TE 3. (I, K) Embryos displaying multinucleation (shown by arrows). Both
multinucleated embryos developed into blastocysts (J and L, respectively) and were suitable for cryopreservation.
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ORIGINAL ARTICLE: ASSISTED REPRODUCTIONThereafter, the blastocysts were quickly moved through three
drops of vitriﬁcation solution containing 15% dimethyl
sulfoxide, 15% ethylene glycol, 10 mg/mL Ficoll-70, and
0.65 M sucrose with 20% SPS, holding for 20 seconds in
each drop. All incubations steps were performed at 37C.
Embryos were loaded with minimal ﬂuid either singly or in
pairs on to the Rapid-i carrier. This plastic stick with blasto-
cysts was quickly dropped into a plastic outer sheath partially
immersed in liquid nitrogen and sealed with an ultrasonic
sealer. Rapid-i straws were placed on cryocanes and stored
in liquid nitrogen tanks.Warming of Blastocysts and Assessment of
Survival
Cryoprotectant was removed by two sequential washes in
warming solutions containing decreasing concentrations of1372sucrose (0.25 M and 0.125 M) in Global medium with 20%
SPS. All steps were performed at 37C with pre-equilibrated
solutions. Warming solutions (0.5 mL) were placed in the cen-
ter well of two organ culture dishes. A third wash dish was set
up with culture medium. After cutting the outer straw, the in-
ner Rapid-i stick was quickly pulled and immersed in the ﬁrst
warming solution (0.25 M sucrose) to unload the embryos.
After a 2-minute incubation, the embryos were transitioned
to the second warming solution (0.125 M sucrose) for 3 mi-
nutes, followed by 5 minutes of incubation in culture me-
dium. Blastocysts were then moved to fresh culture medium.
Immediately after warming, blastocysts were assisted-
hatched using a Hamilton-Thorne 1.48-mm diode laser. Two
to three laser pulses were delivered to open the zonae. The
warmed blastocysts were placed in 25-mL drops of Global
medium with 10% SPS under an oil overlay and examined
under an inverted microscope at 300 magniﬁcation.VOL. 106 NO. 6 / NOVEMBER 2016
Fertility and Sterility®Cryosurvival of vitriﬁed-warmed blastocysts was deter-
mined on the basis of morphology immediately after warm-
ing. Blastocysts with dark, granular appearing cells and
large areas of degeneration were identiﬁed as nonsurviving.
Warmed blastocysts were cultured for 2 to 3 hours and then
reassessed. Blastocoel expansion, TE organization, and ICM
presence and its cohesiveness were once again scored. A
photographic record was kept of blastocyst morphology
immediately after warming and just before transfer. After
assessment of morphology, the blastocysts were moved to
an organ culture dish containing Embryo Glue (Vitrolife) in
preparation for the transfer procedure.Endometrial Preparation and Embryo Transfer
The uterine cavity was assessed before all transfer cycles by
use of ofﬁce hysteroscopy or saline ultrasound. Only patients
with a normal uterine cavity were allowed to proceed. The
patients were prepared for frozen embryo transfer using
endometrial priming with daily oral estradiol valerate
(6 mg) beginning on cycle day 1 and continued for at least
13 days. A transvaginal ultrasonogram was then performed
to assess the endometrial thickness and echo pattern. Once
the endometrium had reached 8 mmwith a trilaminar appear-
ance, intramuscular progesterone injections (50–100 mg)
were started in the evening, and blastocysts were transferred
after 6 days of progesterone therapy. Cycles were canceled if
the endometrial thickness was<8 mm and/or the pattern was
homogeneous. Some cycles required additional transdermal
or transvaginal estrogen until optimal endometrial thickness
and morphology were obtained.
Transfer of vitriﬁed-warmed blastocysts was performed
after 6 days of progesterone treatment. Embryo transfer was
performed under transabdominal ultrasound guidance using
a Wallace Sure-View catheter. Progesterone and estrogen
supplementation was continued for luteal support until
10 weeks of pregnancy.Outcome Parameters
Blastocyst survival and morphology before transfer were
monitored. The serum level of human chorionic gonadotropin
(hCG) was measured 14 days after transfer to detect preg-
nancy. A clinical pregnancy was conﬁrmed by visualization
of an intrauterine gestational sac with fetal heart activity
on ultrasound 5 weeks after the embryo transfer. The implan-
tation rate was calculated by dividing the number of gesta-
tional sacs by the number of embryos transferred. The
clinical pregnancy rate and live-birth rate are expressed per
transfer procedure.Data Collection and Statistical Analysis
Continuous data and categorical variables are expressed as
mean standard deviation (SD) or as percentages. Univariate
analysis using Student's t test, chi-square test, and Fischer's
exact test as appropriate was performed to compare the frozen
cycle outcome parameters. Logistic regression analysis was
used to create a model to control for potential confounding
factors. Variables in the model included factors deemed toVOL. 106 NO. 6 / NOVEMBER 2016be clinically relevant and those found to be statistically sig-
niﬁcant during univariate analysis such as patient age at
freeze, number of embryos transferred, day of blastocyst for-
mation, presence of multinucleation, and blastocyst grade
after warming. Odds ratios and 95% CI were calculated. Sta-
tistical analysis was performed using the software package
JMP (SAS, Inc.). P< .05 was considered statistically
signiﬁcant.RESULTS
Clinical outcome data from 358 consecutive vitriﬁcation-
warming cycles resulting in 354 transfers were analyzed. No
cycles were excluded. The mean patient age at blastocyst
vitriﬁcation was 35.8  4.4 years. Sixteen of the patients
had a repeat cycle. A total of 669 vitriﬁed-warmed blastocysts
were assessed. The overall survival rate for vitriﬁed-warmed
blastocysts was 95%. The mean number of blastocysts trans-
ferred per FET cycle was 1.7 0.5. The resultant implantation
rate per embryo transferred was 43%, with 55% of patients
(n ¼ 193) achieving a clinical pregnancy. The multiple preg-
nancy rate was 27%. No high-order multiple pregnancies
occurred. The live-birth rate with vitriﬁed-warmed blasto-
cysts was 46% with a total of 201 infants delivered (77%
singleton and 23% twin deliveries).
Table 1 summarizes our overall clinical results and also
stratiﬁes the data according to the day of blastocyst vitriﬁca-
tion. Among the 354 transfers, 179 involved day-5 vitriﬁed
blastocysts (50.5%), 146 day-6 vitriﬁed blastocysts (41.3%),
and 29 transfers with both day-5 and day-6 blastocysts
(8.2%). Distinct differences were evident in cycle outcome
data between the two groups. The implantation rate per blas-
tocyst transferred was statistically signiﬁcantly higher for
day-5 blastocysts compared with day-6 blastocysts (50% vs.
29%, respectively; P¼ .002). Expanded day-5 blastocysts
(grades 3 to 4) implanted at a higher rate than the day-6 blas-
tocysts with the same expansion grade (58% vs. 36%;
P< .001). Delayed blastulation also had a statistically signif-
icant negative impact on both achieving pregnancy (40%
vs. 65% for day-5 blastocysts; P< .001) as well as the live-
birth rate (32% vs. 58% with day-5 blastocysts; P< .001).
Table 2 presents the correlations between individual
variables and reproductive outcomes using univariate logis-
tic regression analysis. First, it is important to note that our
FET outcomes were not inﬂuenced by whether the initial
culture to blastocyst had been performed in a conventional
incubator (n ¼ 175) or in the EmbryoScope chamber (n ¼
169). The day 5/day 6 blastocyst ratio was also not different
(conventional 52%/48% versus EmbryoScope 59%/40%; P¼
not statistically signiﬁcant [NS]). The odds ratio for both
clinical pregnancy (OR 2.86; 95% CI, 1.82–4.50; P< .001)
and live birth (OR 2.83; 95% CI, 1.80–4.49; P< .001) were
statistically signiﬁcantly increased with the transfer of a
day-5 blastocyst.
In this univariate model, blastocyst expansion grade after
warming had the strongest association with the clinical preg-
nancy rate (OR 7.10; 95% CI, 2.73–19.5; P< .001) and live-
birth rate (OR 7.19; 95% CI, 2.68–20.27; P< .001). An increase
of TE score from 1 to 3 was indicative of a poorer grade1373
TABLE 1
Comparison of clinical outcomes and live birth rates with day-5 and day-6 vitriﬁed blastocysts.
Outcome All cycles D5 BL D6 BL P value
Patient age at cryopreservation (y) 35.8  4.4 35.2  4.7 36.5  4.2 .007
No. of warming cycles 358 181 148 –
No. of transfers 354 179 146 –
Total blastocysts warmed 669 337 262 –
Survival rate 95% 98% 93% .004
Mean blastocysts transferred 1.7  0.5 1.8  0.5 1.6  0.6 < .001
Implantation rate 43% (264/614) 50% (156/314) 29% (70/239) .002
Implantation rate for EBL 48% (221/462) 58% (133/231) 36% (68/187) < .001
Positive hCG 68% (242/354) 77% (138/179) 55% (80/146) .004
Clinical pregnancy rate 55% (193/354) 65% (117/179) 40% (58/146) < .001
Live-birth rate 46% (163/354) 58% (104/179) 32% (47/146) < .0001
Multiple pregnancy rate 27% (53/193) 34% (40/117) 19% (11/58) .04
Total infants delivered 201 104 54 –
Singleton/twins 77%/23% 72%/28% 85%/15% –
Sex ratio boys/girls 44%/56% 47%/53% 35%/65% –
Birth weight (g) 2,990  754 2,922  778 3,136  552 .04
Note: Cycle outcome parameters are compared for transfers with day-5 versus day-6 vitriﬁed blastocysts. Thaw cycles with both day-5 and day-6 vitriﬁed blastocysts (n¼ 29) are excluded from the
comparative analysis. P< .05 was considered statistically signiﬁcant. BL ¼ blastocyst; D¼ day; EBL ¼ expanded blastocyst; hCG ¼ human chorionic gonadotropin.
Desai. Blastocyst vitriﬁcation and live-birth rate. Fertil Steril 2016.
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONblastocyst, and this statistically signiﬁcantly reduced both the
pregnancy (OR 0.50; 95% CI, 0.33–0.74; P< .001) and live-
birth rates (OR 0.44; 95% CI, 0.28–0.66; P< .001). The ICM
score impacted outcomes in much the same manner.
Increasing ICM score indicated either the absence of an ICM
or inability to visualize the ICM; the latter might be the caseTABLE 2
Variables affecting clinical pregnancy and live-birth rates in frozen-
embryo transfer cycles.
Variable OR (95% CI) P value
Clinical pregnancy rate
D5 vs. D6 2.86 (1.82–4.50) < .001
No. embryo transferred
(per embryo)
2.26 (1.48–3.49) < .001
Patient age at freeze (y) 0.40 (0.13–2.50) .09
Presence of MU 0.51 (0.28–0.93) .04
Blast expansion grade
(all grades)
7.10 (2.73–19.5) < .001
Per grade increase 1.63 (1.28–2.10) < .001
ICM grade (per score increase) 0.63 (0.46–0.85) .003
TE grade (per score increase) 0.50 (0.33–0.74) < .001
Culture chamber 1.14 (0.74–1.75) .59
Live-birth rate
D5 vs. D6 2.83 (1.80–4.49) < .001
No. embryo transfer
(per embryo)
1.90 (1.25–2.91) .003
Patient age at freeze (y) 0.26 (0.09–0.74) .01
Presence of MU 0.44 (0.22–0.80) .01
Blastocyst expansion grade
(all grades)
7.19 (2.68–20.7) < .001
Per grade increase 1.64 (1.28–2.13) < .001
ICM grade (per score increase) 0.65 (0.47–0.88) .006
TE grade (per score increase) 0.44 (0.28–0.66) < .001
Culture chamber 1.20 (0.79–1.86) .45
Note: Univariate logistic regression analysis used to analyze factors potentially affecting
clinical pregnancy and live-birth rate. P< .05 was considered statistically signiﬁcant.
CI ¼ conﬁdence interval; D ¼ day; ICM ¼ inner cell mass; MU ¼ multinucleated;
OR ¼ odds ratio; TE ¼ trophectoderm.
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1374in early blastocysts, resulting in lower odds of both pregnancy
(OR 0.63; 95% CI, 0.46–0.85; P¼ .003) and birth (OR 0.65;
95% CI, 0.47–0.88; P¼ .006).
Multinucleation strongly impacted pregnancy outcome.
The live-birth rates were statistically signiﬁcantly lower
with blastocysts developing from multinucleated embryos
(OR 0.44; 95% CI, 0.22–0.80; P¼ .011). In assessing overall
incidence of multinucleation (n ¼ 146), we found it to be
similar among day-5 and day-6 blastocysts (24% vs. 22%,
respectively). Two other confounding variables assessed
with univariate analysis were patient age at vitriﬁcation
and number of embryos transferred. Whereas age at cryopres-
ervation did not signiﬁcantly impact pregnancy rates (OR
0.40; 95% CI, 0.13–2.50; P¼ .09), the live-birth rate was
signiﬁcantly negatively inﬂuenced by increasing patient
age (OR 0.26; 95% CI, 0.09–0.74; P¼ .012). As might be ex-
pected, pregnancy (OR 2.26; 95% CI, 1.48–3.49; P< .001)
and live-birth rates (OR 1.90; 95% CI, 1.25–2.91; P¼ .003)
were strongly associated with the number of embryos
transferred.
A multivariate logistic regression model for the clinical
pregnancy and live-birth rates is shown in Table 3. Con-
founding variables identiﬁed as statistically signiﬁcantly
impacting reproductive outcomes were combined to
construct this predictive model. The ICM and TE scores
were not included as their scoring has a partial dependence
on blastocyst expansion. Blastocyst expansion was therefore
used as an independent binary variable to serve as the sole
morphologic predictor in our model. Expanded blastocysts
(grades 3 to 4) were compared with nonexpanded blastocysts
(grades 1 to 2).
The association between age at cryopreservation and the
live-birth rate no longer reached statistical signiﬁcance
(P¼ .06) when the confounding variables were taken in to
account; the number of embryos transferred continued to pre-
dict pregnancy rates (OR 3.16; 95% CI, 1.20–8.36; P¼ .02), but
not the odds of live birth (2.42; 95% CI, 0.90–6.53; P¼ .08).VOL. 106 NO. 6 / NOVEMBER 2016
TABLE 3
Logistic regression model for clinical pregnancy and live births in
frozen-embryo transfer cycles.
Variable OR (95% CI) P value
Clinical pregnancy rate
D5 vs. D6 3.08 (1.88–5.12) < .001
Patient age at freeze (y) 0.53 (0.15–1.77) .30
Presence of MU 0.55 (0.28–1.08) .08
Expanded blastocyst 4.05 (2.31–7.28) < .001
No. embryos transferred 3.16 (1.20–8.36) .02
Live-birth rate
D5 vs. D6 2.93 (1.79–4.85) < .001
Patient age at freeze (y) 0.31 (0.09–1.04) .06
Presence of MU 0.46 (0.22–0.91) .03
Expanded blastocyst 3.84 (2.15–7.09) < .001
No. of embryos
transferred
2.42 (0.90–6.53) .08
Note: Confounding variables shown to be have a signiﬁcant effect on pregnancy and live-
birth rate after univariate logistic analysis were used to construct this multivariate logistic
regression model to assess outcome data. P< .05 was considered statistically signiﬁcant.
CI ¼ conﬁdence interval; D ¼ day; MU ¼ multinucleated; OR ¼ odds ratio.
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Fertility and Sterility®The latter ﬁndings may be explained by the fact that more
embryos were transferred in older patients to maintain the
pregnancy rates, but those embryos have an elevated risk
for pregnancy loss due to aneuploidy.
From this multivariate model, we observed that the day of
blastocyst formation was strongly predictive of clinical
outcome. An embryo blastulating by culture day 5 was three
times as likely as an embryo blastulating by day 6 to give rise
to a clinical pregnancy (3.08; 95% CI, 1.88–5.12; P< .001) as
well as live birth (OR 2.93; CI, 1.79–4.85; P< .001) in a subse-
quent frozen transfer cycle, irrespective of patient age.
Furthermore, the chance of clinical pregnancy (OR 4.05;
95% CI, 2.31–7.28; P< .001) and live birth (OR 3.84; 95%
CI, 2.15–7.09; P< .001) were about 4 times higher if an
expanded blastocyst was transferred. There was a clear
independent association of multinucleation with decreased
live-birth rate. Blastocysts formed from cleavage embryos
exhibiting multinucleation were half as likely to result in a
live birth (OR 0.46; 95% CI, 0.22–0.91; P¼ .03).
In this study we had 106 eSET cycles. When the data were
analyzed with just these cases, the results were in agreement
with the model presented in Table 3. The odds of pregnancy
(OR 6.6; 95% CI, 2.56–19.39; P< .001) and live birth (OR
6.6; 95% CI, 2.57–20.51; P< .001) were statistically signiﬁ-
cantly greater with day-5 vitriﬁed blastocysts. The presence
of an expanded/blastocyst increased the odds of pregnancy
(OR 5.17; 95% CI, 1.85–16.4; P< .01) as well as live birth
(OR 4.47; 95% CI, 1.54–14.98; P< .01). We found that eSETs
with non-multinucleated embryos resulted in threefold higher
pregnancy and live-birth rates (P¼ .02). With this limited data
set, the age at freezing did not statistically signiﬁcantly affect
the clinical pregnancy or live-birth rates.DISCUSSION
With the growing emphasis on blastocyst cryopreservation, a
clearer understanding of the factors inﬂuencing successfulVOL. 106 NO. 6 / NOVEMBER 2016FET cycle outcomes is of vital importance. Perhaps one of
the most controversial questions is the developmental compe-
tency of embryos with delayed blastulation. Fresh blastocyst
transfer data indicate that slow growing embryos not blastu-
lating until day 6 have lower pregnancy potential (9, 10, 21).
The close relationship between timely cell division and
developmental competence is further supported by kinetic
data from time-lapse culture systems (4, 6, 7). Embryo
morphokinetics combined with preimplantation genetic
screening has been used to model a risk-classiﬁcation system
for aneuploidy. Applying this model, embryos exhibiting
delayed initiation of blastulation were found to be at a higher
risk for aneuploidy (22). Yet others contend that the euploidy
rate is similar between day-5 and slow-growing day-6
blastocysts (23). Yang et al. (24) point to a non-statistically-
signiﬁcant trend toward increased pregnancy and implanta-
tion rates when euploid blastocysts with early initiation of
blastulation are compared with euploid blastocysts with
delayed initiation times (24).
Asynchrony between the patient's endometrium and em-
bryo development in fresh blastocyst transfers may explain
the differing ﬁndings in the published literature. Frozen
transfer cycles, where endometrial preparation can be more
uniform, should provide a better platform for assessing the
competence of day-5 versus day-6 blastocysts. Unfortu-
nately, the conﬂicting data from FET studies have left the
question of the overall competency of late blastulating
embryos unresolved (11, 25–31).
In the present work with cryopreserved blastocysts,
delayed blastulation negatively impacted embryo competence
to implant. Controlling for confounding variables such as
patient age, number of embryos transferred, blastocyst grade,
and multinucleation did not diminish this effect. The preg-
nancy and live-birth rates were three times higher after trans-
fer of day-5 vitriﬁed-warmed blastocysts compared with
embryos blastulating on day 6.
Our ﬁndings are in agreement with several other studies.
Levens et al. (28) reported a statistically signiﬁcant increase in
the implantation rate and a non-statistically-signiﬁcant trend
toward more live births with day-5 cryopreserved blastocysts
(28). The lower implantation potential of day-6 vitriﬁed blas-
tocysts was also noted by Kang et al. (32) when comparing the
efﬁciency of single versus double embryo transfers based on
day of vitriﬁcation. On the other hand, a study on perinatal
outcomes from the transfer of blastocysts vitriﬁed on days
5, 6, or 7 suggested that blastocysts have similar inherent
viability regardless of day of cryopreservation (27).
El-Toukhy et al. (26) also reported the live-birth rate to be
similar between day 5 and day 6 vitriﬁed embryos (29%).
Wide variations in laboratory protocols, culture tech-
niques, criteria for blastocyst freezing, and the cryopreserva-
tion methodology itself may explain the current
contradictions in the literature regarding the implantation
potential of day-5 versus day-6 blastocysts (31). The cause
of delayed blastulation could be intrinsic to the embryo or
the result of a less than optimal in vitro culture environment
that is negatively inﬂuencing embryo development. Reduc-
tion in day-6 blastocyst clinical performance might possibly
be associated with nutrient depletion from the culture milieu.1375
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONNevertheless, the live-birth rate of 58% for day-5 vitriﬁed
blastocysts compared with 32% for day-6 blastocysts sug-
gests that, within our laboratory, protocols have been opti-
mized for blastocyst development by day 5. Embryos not
developing to blastocyst within this time frame have mark-
edly reduced potential. These data encourage the adoption
of a policy of eSET in FET cycles where day-5 expanded blas-
tocysts with no multinucleation are available for transfer.
Blastocyst morphology based on blastocoel expansion,
TE, and ICM must also be considered in evaluating FET out-
comes. We found that the single most important factor corre-
lating to blastocyst implantation in FET cycles was the degree
of expansion before transfer. This was independent of the day
of blastocyst formation. Blastocysts of grades 3 to 4 formed
by day 5 were four times as likely to result in a live birth
compared with a similarly graded slow-growing day-6
blastocyst.
We also tried to gauge the contribution of the ICM and TE
scores to success rates. In the univariate analysis, both preg-
nancy and live-birth rates statistically signiﬁcantly decreased
as the ICM and TE scoring went from 1 (good) to 3 (poor).
Several studies have attempted to discern which of these
two characteristics is most associated with positive outcomes.
ICM size and shape were predictive of which blastocysts were
most likely to implant by Richter et al. (33). Others have pre-
sented data linking TE grade to implantation potential in fresh
as well as frozen cycles (34, 35). One of the difﬁculties in
interpreting the data on the relative importance of the TE
versus ICM score is that the scoring of these components is
so closely intertwined with the degree of blastocyst
expansion. For example, an early less mature blastocyst
(grades 1–2) with good morphologic features by the current
scoring system would still get a low ICM score of only 2 or
3 because ICM visualization and the evaluation of
cohesiveness are clearest after expansion to a grade-3 blasto-
cyst. A similar confounder exists with TE scoring. For this
reason, we elected to construct our outcome model with just
expansion grade because it was representative of the level
of blastocyst maturity.
The last question we addressed was the impact of multi-
nucleation on reproductive outcomes. Multinucleation
observed during early cleavage stage has historically been
used to deselect embryos for fresh transfer due to lower preg-
nancy rates (4, 14, 16, 36). The implantation potential of such
multinucleated embryos that develop to freeze-quality blasto-
cysts has been unclear. Our laboratory policy has therefore
been to cryopreserve and track all good-quality blastocysts
arising from multinucleated embryos. Understanding the
reproductive competence of these embryos has become
particularly vital since the integration of time-lapse micro-
scopy in our laboratory. Continuous monitoring of embryos
with time-lapse microscopy has revealed that 25% to 30%
of zygotes display multinucleation ﬂeetingly during early
cleavage yet go on to form high-grade blastocysts.
The present work is one of the ﬁrst to monitor the preg-
nancy potential of vitriﬁed-warmed blastocysts derived
frommultinucleated embryos. The OR of achieving a live birth
from cryopreserved multinucleated blastocysts was reduced1376to about half of those without multinucleation (OR 0.46;
95% CI 0.22–0.91). Examining our own preimplantation ge-
netic screening data (unpublished) as well as that of others
has made it evident that not all multinucleated embryos are
aneuploid (17, 37). The clinical outcome is likely dictated
by the disposition of the multinucleated blastomere within
the developing blastocyst. Little is still known about
this dysmorphism and subsequent cellular events.
Multinucleated cells may end up fragmenting, becoming
excluded during compaction, or ending up in the TE and/or
ICM, resulting in a mosaic embryo.
Information on blastocyst competency has practical
value both in the laboratory and in patient cycle manage-
ment. For the laboratory it might make sense to freeze all
day-5 embryos singly due their high implantation rates
whereas the freezing of day-6 blastocysts in pairs may have
merit, simultaneously saving technician time as well as valu-
able freezer space. Likewise, blastocysts from multinucleated
embryos should be clearly identiﬁed and cryopreserved sepa-
rate from non-multinucleated counterparts. Decision making
regarding single- or double-embryo transfer in a subsequent
frozen cycle may beneﬁt from considering the implantation
potential of the frozen blastocysts available. Ultimately, peri-
natal outcomes may be enhanced by adoption of a policy of
eSET in FET cycles with optimal embryos.
The cryopreservation methodology also needs mention.
Although vitriﬁcation is being widely used for blastocyst
cryopreservation, the technology is far from standardized.
Cryoprotectant type and concentrations, equilibrations times,
and vitriﬁcation devices and their respective cooling rates are
just a few of the factors involved that vary among labora-
tories. The Rapid-i carrier used in this investigation is rela-
tively new to the marketplace. The cooling rate with this
device (1,200C/min) is far lower than other vitriﬁcation de-
vices but still allows aseptic non-contact vitriﬁcation (19).
Tailoring the vitriﬁcation methodology to accommodate
both early-stage and late-stage blastocysts is also important.
Expanded blastocysts with their large ﬂuid content are partic-
ularly vulnerable during cryopreservation (20, 38). Artiﬁcial
collapse of blastocysts to reduce ﬂuid volume permitted the
shortening of equilibration times while maintaining high
survival rates for blastocysts of all expansion grades. The
live-birth data presented in this study add to the limited
pool of published data on neonatal outcomes with blastocysts
vitriﬁed using the Rapid-i carrier (19).
The limitations of the current study are of course its retro-
spective nature. We also acknowledge that the timing of blas-
tocyst expansion and cell line allocation to ICM–TE is
independent of each other, but both are highly dependent
on speciﬁc culture conditions. Confounding variables were
controlled for during data analysis, but a prospective, statis-
tically powered study is needed to conﬁrm our observations.
Moreover, it remains to be seen whether this model can be
applied to other laboratories culturing blastocysts under
different conditions. Finally, this study was focused primarily
on embryo-speciﬁc aspects contributing to outcomes with
frozen blastocysts. The only patient-speciﬁc demographics
looked at were diagnosis, age at freeze, and number ofVOL. 106 NO. 6 / NOVEMBER 2016
Fertility and Sterility®embryos elected for transfer. Therefore, we cannot account
for any potential effects of a speciﬁc stimulation regimen or
cycle-speciﬁc parameter on the intrinsic quality of the blasto-
cyst being cryopreserved. Nevertheless, the current data pro-
vide valuable insight into blastocyst-speciﬁc factors
associated with high pregnancy and live-birth rates.
With ever evolving IVF technology, detailed analysis of
embryo implantation potential plays an important role in as-
sessing and dissecting out gamete- and embryo-related fac-
tors versus culture inﬂuence on clinical outcomes. Although
slower-growing day-6 blastocysts can lead to acceptable
FET clinical outcomes, our results would suggest that selec-
tion of embryos blastulating a day earlier offers a distinct
advantage and may be prognostic for enhanced blastocyst
potential. Blastocysts deselected from fresh transfer due to
multinucleation should continue to be cryopreserved for
future use as they can result in a live birth. It is imperative
that laboratories critically evaluate their own clinic-speciﬁc
data to better understand the developmental competency of
the blastocysts being cryopreserved.
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